First Horizon Advisors, Inc. - TAKEDA PHARMACEUTICAL CO LTD ownership

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 14 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
First Horizon Advisors, Inc. ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q3 2023$5,986
+25.8%
387
+27.7%
0.00%
Q2 2023$4,760
-77.2%
303
-76.1%
0.00%
-100.0%
Q1 2023$20,895
+118.5%
1,268
+106.9%
0.00%
Q4 2022$9,562
+139.0%
613
+68.9%
0.00%
Q3 2022$4,000
-20.0%
3630.0%0.00%
Q2 2022$5,000363
+967.6%
0.00%
Q1 2022$0
-100.0%
34
-92.8%
0.00%
Q4 2021$6,000
-14.3%
4750.0%0.00%
Q3 2021$7,000
-61.1%
475
-56.1%
0.00%
-100.0%
Q2 2021$18,000
+100.0%
1,082
+116.0%
0.00%0.0%
Q1 2021$9,000
+12.5%
501
+11.1%
0.00%0.0%
Q4 2020$8,000
+14.3%
4510.0%0.00%0.0%
Q3 2020$7,000
+75.0%
451
+112.7%
0.00%
Q1 2019$4,000
+300.0%
212
+226.2%
0.00%
Q3 2018$1,0000.0%650.0%0.00%
Q2 2018$1,0000.0%650.0%0.00%
Q1 2018$1,0000.0%650.0%0.00%
Q4 2017$1,0000.0%65
-7.1%
0.00%
Q3 2017$1,0000.0%700.0%0.00%
Q2 2017$1,0000.0%70
-6.7%
0.00%
Q1 2017$1,00075
+316.7%
0.00%
Q4 2016$0180.0%0.00%
Q3 2016$018
+50.0%
0.00%
Q2 2016$0120.0%0.00%
Q1 2016$012
+300.0%
0.00%
Q4 2015$030.0%0.00%
Q3 2015$030.00%
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q2 2018
NameSharesValueWeighting ↓
Adelphi Capital LLP 7,584,930$138,046,00026.79%
Glenview Capital Management 15,260,512$277,741,0006.37%
Paulson & Co. 11,295,846$205,584,0005.34%
GMT CAPITAL CORP 2,871,395$52,259,0003.72%
MANAGED ASSET PORTFOLIOS, LLC 966,643$17,593,0003.09%
TFG Asset Management GP Ltd 1,443,052$26,264,0001.76%
Mondrian Investment Partners LTD 3,274,660$58,944,0001.46%
Blackcrane Capital, LLC 35,236$641,0001.26%
Lumbard & Kellner, LLC 136,378$2,404,0000.95%
DAVIDSON INVESTMENT ADVISORS 509,800$9,278,0000.86%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders